Premium
In vivo activation of gelatinase B/MMP‐9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin‐induced diabetes
Author(s) -
Descamps Francis J,
Martens Erik,
Ballaux Florence,
Geboes Karel,
Opdenakker Ghislain
Publication year - 2004
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.1669
Subject(s) - streptozotocin , endocrinology , gelatinase a , diabetes mellitus , medicine , gelatinase , trypsin , acute pancreatitis , pancreatitis , trypsinogen , pancreas , matrix metalloproteinase , chemistry , enzyme , biochemistry
Matrix metalloproteinases, in particular gelatinase B/MMP‐9, are key mediators in autoimmune diseases like multiple sclerosis and rheumatoid arthritis, but their pathogenic roles in diabetes are not well established. Gelatinase B has previously been shown to be upregulated in pancreas tissue from patients with acute and chronic pancreatitis and was suggested to exacerbate diabetes by cleaving insulin. In this study, the role of gelatinase B in diabetes was investigated using two streptozotocin‐induced animal models of type I diabetes. In both a hyperacute and a subacute model, gelatinase B upregulation was found to be associated with disease activity. However, gelatinase B deficiency did not significantly protect against diabetes development, and wild‐type and gelatinase B‐deficient animals behaved similarly in terms of β‐cell apoptosis or necrosis. The fact that gelatinase B was found almost exclusively as the inactive pro‐enzyme in most of the streptozotocin‐induced diabetic animals may explain the lack of a gelatinase B effect. On the contrary, gelatinase B was completely activated in a minority (15%) of wild‐type animals. This coincided with exocrine pancreatic inflammation, as revealed by the presence of active trypsin. The discovery of in vivo activation of progelatinase B by trypsin in acute pancreatitis is extended in a model of caerulein‐induced pancreatitis. In the latter model, trypsinogen activation is systematically achieved and gelatinase B is found in its active form. In conclusion, gelatinase B itself is not a causative factor but, when activated by endogenous trypsin, is a permissive factor for insulin degradation and diabetes. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.